|Table of Contents|

UCHL1 promotes the proliferation and metastasis of lung cancer cells by regulating glycolytic metabolism in tumor microenvironment

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 16
Page:
2975-2981
Research Field:
Publishing date:

Info

Title:
UCHL1 promotes the proliferation and metastasis of lung cancer cells by regulating glycolytic metabolism in tumor microenvironment
Author(s):
LI AikeLIN PingpingZHAO JiweiGUO YanZHANG LiguangLI FuboDONG YiDU Xinsheng
Department of Oncology,Affiliated Hospital of Chengde Medical College,Hebei Chengde 067000,China.
Keywords:
lung cancerubiquitin C-terminal hydrolase-L1 (UCHL1)glycolysisproliferationmetastasis
PACS:
R734.2
DOI:
10.3969/j.issn.1672-4992.2024.16.008
Abstract:
Objective:To explore the effect of ubiquitin C-terminal hydrolase-L1 (UCHL1) on the proliferation and metastasis of lung cancer cells by regulating hypoxia-inducible factor 1 (HIF-1) mediated metabolic reprogramming.Methods:Immunohistochemistry and real-time quantitative polymerase chain reaction were used to detect the expression of UCHL1 and HIF-1 in lung cancer tissues and cells.Kaplan-Meier Plotter and UALCAN databases analyzed the correlation between the expression levels of UCHL1 and HIF-1 and patient survival,and further analyzed their expression in tumor tissues of patients with different clinical pathological grades and lymphatic metastasis.Clone formation,migration,and invasion assessment of malignant biological behavior changes in lung cancer HCC4006 cells transfected with UCHL1 siRNA.Western Blot detection of the expression of IL-6/STAT3 markers in tumor cells after silencing UCHL1.Results:Immunohistochemistry,real-time quantitative polymerase chain reaction,and correlation analysis,the results showed that the expressions of UCHL1 and HIF-1 in lung cancer tissues and cells were significantly increased compared with those in adjacent tissues and normal bronchial epithelial cells,and the expression levels of the two were positively correlated (P<0.01),and these results were consistent with the expression trend of UCHL1 and HIF-1 in Oncomine database.The results of bioinformatics analysis showed that the abnormally high expression of UCHL1 and HIF-1 was negatively correlated with the survival time of lung cancer patients,but positively correlated with the pathological grade and lymph node metastasis of patients (P<0.01).The ability of colony formation,migration,and invasion of lung cancer HCC4006 cells transfected with UCHL1 siRNA was significantly reduced compared with the control cells,the oxygen consumption of the cells was significantly increased,and the LDH activity and LD secretion were inhibited (P<0.01).Western Blot results showed that silencing UCHL1 inhibited HIF-1 expression and decreased the expression of tumor cell glycolysis IL-6/STAT3 signaling pathway biomarkers mediated by hypoxia (P<0.01).Conclusion:Lung cancer cells acquire strong proliferative and metastatic phenotypes through metabolic reprogramming mediated by the UCHL1-HIF-1 axis,providing a rationale for therapies targeting this gene network.

References:

[1]PETTY WJ,PAZ-ARES L.Emerging strategies for the treatment of small cell lung cancer:A review [J].JAMA Oncology,2023,9(3):419-429.
[2]DESAI AP,ADASHEK JJ,REUSS JE,et al.Perioperative immune checkpoint inhibition in early-stage non-small cell lung cancer:A review [J].JAMA Oncology,2023,9(1):135-142.
[3]VITALE I,MANIC G,COUSSENS LM,et al.Macrophages and metabolism in the tumor microenvironment [J].Cell Metabolism,2019,30(1):36-50.
[4]TRAYHURN P.Hypoxia and adipose tissue function and dysfunction in obesity [J].Physiological Reviews,2013,93(1):1-21.
[5]DEBERARDINIS RJ,LUM JJ,HATZIVASSILIOU G,et al.The biology of cancer:metabolic reprogramming fuels cell growth and proliferation [J].Cell Metabolism,2008,7(1):11-20.
[6]RRINFELD BI,MADDEN MZ,WOLF MM,et al.Cell-programmed nutrient partitioning in the tumor microenvironment [J].Nature,2021,593(7858):282-288.
[7]NAKASHIMA R,GOTO Y,KOYASU S,et al.UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization [J].Scientific Reports,2017,7(1):6879.
[8]WILSON CL,MURPHY LB,LESLIE J,et al.Ubiquitin C-terminal hydrolase 1:A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease [J].Journal of Hepatology,2015,63(6):1421-1428.
[9]陈巍.肿瘤标志物检验在肺癌诊断中的临床价值分析[J].中国免疫学,2023,38(06):85-87. CHEN W.Clinical value analysis of tumor marker testing in the diagnosis of lung cancer [J].Chinese Immunology,2023,38(06):85-87.
[10]LEI Q,YI T,LI H,et al.Ubiquitin C-terminal hydrolase L1 (UCHL1) regulates post-myocardial infarction cardiac fibrosis through glucose-regulated protein of 78 kDa (GRP78)[J].Scientific Reports,2020,10(1):10604.
[11]LAU S,PAN Y,VELCHETI V,et al.Squamous cell lung cancer:Current landscape and future therapeutic options [J].Cancer Cell,2022,40(11):1279-1293.
[12]LAHIRI A,MAJI A,POTDAR PD,et al.Lung cancer immunotherapy:progress,pitfalls,and promises [J].Molecular Cancer,2023,22(1):40.
[13]LI W,LIU JB,HOU LK,et al.Liquid biopsy in lung cancer:significance in diagnostics,prediction,and treatment monitoring[J].Molecular Cancer,2022,21(1):25.
[14]FRANK AR,LI V,SHELTON SD,et al.Mitochondrial-encoded complex I impairment induces a targetable dependency on aerobic fermentation in Hurthle cell carcinoma of the thyroid [J].Cancer Discovery,2023,32(12):27-32.
[15]LEE J,KIM K,KWON IC,et al.Intracellular glucose-depriving polymer micelles for antiglycolytic cancer treatment [J].Advanced Materials,2023,35(10):e2207342.
[16]FRESQUET V,GARCIA MJ,LARRAYOZ M,et al.Endogenous retroelement activation by epigenetic therapy reverses the Warburg effect and elicits mitochondrial-mediated cancer cell death [J].Cancer Discovery,2021,11(5):1268-1285.
[17]CAMERON AM,CASTOLDI A,SANIN DE,et al.Inflammatory macrophage dependence on NAD salvage is a consequence of reactive oxygen species-mediated DNA damage [J].Nature Immunology,2019,20(4):420-432.
[18]AGATHOCLE M,HARRIS WA.Metabolism in physiological cell proliferation and differentiation [J].Trends in Cell Biology,2013,23(10):484-492.
[19]ICARD P,SIMULA L,FOURNEL L,et al.The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer:Therapeutic implications [J].Drug Resistance Updates,2022,63(21):100852.
[20]GAO H,HARTNETT S,LI Y.Ubiquitin C-terminal hydrolase L1 regulates myoblast proliferation and differentiation [J].Biochemical and Biophysical Research Communications,2017,492(1):96-102.
[21]LI Y,LIH TM,DHANASEKARAN SM,et al.Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness [J].Cancer Cell,2023,41(1):139-163.
[22]TIAN C,LIU Y,LIU Y,et al.UCHL1 promotes cancer stemness in triple-negative breast cancer [J].Pathology,Research and Practice,2022,240(12):154235.

Memo

Memo:
河北省承德市科技项目(编号:202204A071)
Last Update: 1900-01-01